DREXEL MORGAN & CO. – Eli Lilly and Company Transaction History
DREXEL MORGAN & CO. portfolio value:
$647,000
portfolio value
DREXEL MORGAN & CO. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1K | $323.35 | 2K | |
| Q2 2022 | share | 0.00% | 0 shares | 75K | $324.23 | 2K | |
| Q1 2022 | share | 0.00% | 0 shares | 21K | $286.37 | 2K | |
| Q4 2021 | share | 0.00% | 0 shares | 90K | $277.25 | 2K | |
| Q3 2021 | share | Decrease | -20.00% | -500 shares | -112K | $230.3 | 2K |
| Q2 2021 | share | Increase | +25.00% | 500 shares | 200K | $228.04 | 2.5K |
| Q1 2021 | share | Decrease | -0.30% | -6 shares | 35K | $184.81 | 2K |
| Q4 2020 | share | 0.00% | 0 shares | 42K | $166.32 | 2.00K | |
| Q3 2020 | share | 0.00% | 0 shares | -32K | $145.05 | 2.00K | |
| Q2 2020 | share | 0.00% | 0 shares | 51K | $160.1 | 2.00K | |
| Q1 2020 | share | 0.00% | 0 shares | 14K | $134.64 | 2.00K | |
| Q4 2019 | share | Increase | +0.30% | 6 shares | 40K | $126.91 | 2.00K |
| Q3 2019 | share | 0.00% | 0 shares | 2K | $107.36 | 2K | |
| Q2 2019 | share | 0.00% | 0 shares | -38K | $105.74 | 2K | |
| Q1 2019 | share | 0.00% | 0 shares | 29K | $123.17 | 2K | |
| Q4 2018 | share | 0.00% | 0 shares | 16K | $109.26 | 2K | |
| Q3 2018 | share | Increase | 0.00% | 2K shares | 215K | $100.8 | 2K |
| Q1 2018 | share | Decrease | -100.00% | -2.64K shares | -223K | $71.78 | 0 |
| Q4 2017 | share | 0.00% | 0 shares | -3K | $77.79 | 2.64K | |
| Q3 2017 | share | 0.00% | 0 shares | 8K | $78.29 | 2.64K | |
| Q2 2017 | share | Increase | 0.00% | 2.64K shares | 218K | $74.85 | 2.64K |